1.Prediction Models for Suicide Attempts among Adolescents Using Machine Learning Techniques
Jae Seok LIM ; Chan-Mo YANG ; Ju-Won BAEK ; Sang-Yeol LEE ; Bung-Nyun KIM
Clinical Psychopharmacology and Neuroscience 2022;20(4):609-620
		                        		
		                        			 Objective:
		                        			Suicide attempts (SAs) in adolescents are difficult to predict although it is a leading cause of death among adolescents. This study aimed to develop and evaluate SA prediction models based on six different machine learning (ML) algorithms for Korean adolescents using data from online surveys. 
		                        		
		                        			Methods:
		                        			Data were extracted from the 2011−2018 Korea Youth Risk Behavior Survey (KYRBS), an ongoing annual national survey. The participants comprised 468,482 nationally representative adolescents from 400 middle and 400 high schools, aged 12 to 18. The models were trained using several classic ML methods and then tested on internal and external independent datasets; performance metrics were calculated. Data analysis was performed from March 2020 to June 2020. 
		                        		
		                        			Results:
		                        			Among the 468,482 adolescents included in the analysis, 15,012 cases (3.2%) were identified as having made an SA. Three features (suicidal ideation, suicide planning, and grade) were identified as the most important predictors. The performance of the six ML models on the internal testing dataset was good, with both the area under the receiver operating characteristic curve (AUROC) and area under the precision−recall curve (AUPRC) ranging from 0.92 to 0.94. Although the AUROC of all models on the external testing dataset (2018 KYRBS) ranged from 0.93 to 0.95, the AUPRC of the models was approximately 0.5. 
		                        		
		                        			Conclusion
		                        			The developed and validated SA prediction models can be applied to detect high risks of SA. This approach could facilitate early intervention in the suicide crisis and may ultimately contribute to suicide prevention for adolescents. 
		                        		
		                        		
		                        		
		                        	
2.Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE)
Jeong-Yeol PARK ; Ju-Hyun KIM ; Min-Hyun BAEK ; Eunhyang PARK ; Sang Wun KIM
Journal of Gynecologic Oncology 2022;33(6):e73-
		                        		
		                        			 Background:
		                        			Sentinel lymph node (SLN) mapping has been suggested as an alternative surgical technique to full lymphadenectomy for early-stage endometrial cancer. However, the survival outcomes of SLN mapping compared with lymphadenectomy have not been established via a prospective study. 
		                        		
		                        			Methods
		                        			A multi-center, single-blind, randomized controlled trial has been designed to determine the prognostic value of SLN mapping alone compared with conventional lymphadenectomy for patients with clinical stage I-II endometrial cancer. Eligible participants will be randomly assigned in a 1:1 ratio between the group to undergo SLN mapping using indocyanine green and the conventional lymph node dissection group. A high-risk group will undergo a 2-step SLN mapping procedure. The primary endpoint is the 3-year disease-free survival (DFS). The secondary endpoints are 3-year overall survival (OS), 5-year DFS, 5-year OS after surgery, pattern of recurrence, immediate surgical outcomes, success rate of SLN mapping, postoperative lymph-related complications, postoperative quality of life, and postoperative cost effectiveness. The role of pathologic ultrastaging of SLNs will also be assessed. 
		                        		
		                        		
		                        		
		                        	
3.Antibiotic Treatment of Vertebral Osteomyelitis caused by Methicillin-Susceptible Staphylococcus aureus: A Focus on the Use of Oral β-lactams
Won Sup OH ; Chisook MOON ; Jin Won CHUNG ; Eun Ju CHOO ; Yee Gyung KWAK ; Si Hyun KIM ; Seong Yeol RYU ; Seong Yeon PARK ; Baek Nam KIM
Infection and Chemotherapy 2019;51(3):284-294
		                        		
		                        			 BACKGROUND:
		                        			Vertebral osteomyelitis (VO) is a rare but serious condition, and a potentially significant cause of morbidity. Methicillin-susceptible Staphylococcus aureus (MSSA) is the most common microorganism in native VO. Long-term administration of parenteral and oral antibiotics with good bioavailability and bone penetration is required for therapy. Use of oral β-lactams against staphylococcal bone and joint infections in adults is not generally recommended, but some experts recommend oral switching with β-lactams. This study aimed to describe the current status of antibiotic therapy and treatment outcomes of oral switching with β-lactams in patients with MSSA VO, and to assess risk factors for treatment failure.
		                        		
		                        			MATERIALS AND METHODS:
		                        			This retrospective study included adult patients with MSSA VO treated at nine university hospitals in Korea between 2005 and 2014. Treatment failure was defined as infection-related death, microbiological relapse, neurologic deficits, or unplanned surgical procedures. Clinical characteristics and antibiotic therapy in the treatment success and treatment failure groups were compared. Risk factors for treatment failure were identified using the Cox proportional hazards model.
		                        		
		                        			RESULTS:
		                        			A total of 100 patients with MSSA VO were included. All patients were treated, initially or during antibiotic therapy, with one or more parenteral antibiotics. Sixty-nine patients received one or more oral antibiotics. Antibiotic regimens were diverse and durations of parenteral and oral therapy differed, depending on the patient and the hospital. Forty-two patients were treated with parenteral and/or oral β-lactams for a total duration of more than 2 weeks. Compared with patients receiving parenteral β-lactams only, no significant difference in success rates was observed in patients who received oral β-lactams for a relatively long period. Sixteen patients had treatment failure. Old age (adjusted hazard ratio [HR] 5.600, 95% confidence interval [CI] 1.402 – 22.372, P = 0.015) and failure to improve C-reactive protein levels at follow-up (adjusted HR 3.388, 95% CI 1.168 – 9.829, P = 0.025) were independent risk factors for treatment failure.
		                        		
		                        			CONCLUSION
		                        			In the study hospitals, diverse combinations of antibiotics and differing durations of parenteral and oral therapy were used. Based on the findings of this study, we think that switching to oral β-lactams may be safe in certain adult patients with MSSA VO. Since limited data are available on the efficacy of oral antibiotics for treatment of staphylococcal VO in adults, further evaluation of the role of oral switch therapy with β-lactams is needed. 
		                        		
		                        		
		                        		
		                        	
4.Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis.
Jwa Hoon KIM ; Sook Ryun PARK ; Min Hee RYU ; Baek Yeol RYOO ; Kyu pyo KIM ; Beom Su KIM ; Moon Won YOO ; Jeong Hwan YOOK ; Byung Sik KIM ; Jihun KIM ; Sun Ju BYEON ; Yoon Koo KANG
Cancer Research and Treatment 2018;50(2):518-529
		                        		
		                        			
		                        			PURPOSE: The purpose of this study was to evaluate the efficacy and safety of induction chemotherapy with docetaxel, capecitabine, and cisplatin (DXP) plus bevacizumab (BEV) on initially unresectable locally advanced gastric cancer (LAGC) or paraaortic lymph node (PAN) metastatic gastric cancer (GC). MATERIALS AND METHODS: Patients with LAGC or unresectable PAN metastatic GC received six induction chemotherapy cycles (60 mg/m2 docetaxel intravenously on day 1, 937.5 mg/m2 capecitabine orally twice daily on days 1-14, 60 mg/m2 cisplatin intravenously on day 1, and 7.5 mg/kg BEV intravenously on day 1 every 3 weeks), followed by conversion surgery. The primary endpoint was R0 resection rate. RESULTS: Thirty-one patients with invasion to adjacent organs but without PAN metastasis (n=14, LAGC group) or with PAN metastasis regardless of invasion (n=17, PAN group) were enrolled between July 2010 and December 2014. Twenty-seven patients (87.1%) completed six chemotherapy cycles. The most common grade ≥ 3 toxicities were neutropenia (71%), neutropenia with fever/infection (22.6%/3.2%), and stomatitis (16.1%). The clinical response and R0 resection rates were 64.3% (95% confidence interval [CI], 46.6 to 82.0) and 64.5% (LAGC group, 71.4%; PAN group, 58.8%), respectively. The pathological complete regression rate was 12.9%. After a median follow-up of 44.5 months (range, 39.4 to 49.7 months), the median progression-free survival and overall survival were 13.1 months (95% CI, 8.9 to 17.3) and 38.6 months (95% CI, 22.0 to 55.1), respectively. CONCLUSION: Induction chemotherapy with DXP+BEV displayed antitumor activities with encouraging R0 resection rate and manageable toxicity profiles on patients with LAGC or PAN metastatic GC.
		                        		
		                        		
		                        		
		                        			Bevacizumab*
		                        			;
		                        		
		                        			Capecitabine*
		                        			;
		                        		
		                        			Cisplatin*
		                        			;
		                        		
		                        			Disease-Free Survival
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Gastrectomy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Induction Chemotherapy*
		                        			;
		                        		
		                        			Lymph Nodes*
		                        			;
		                        		
		                        			Neoplasm Metastasis*
		                        			;
		                        		
		                        			Neutropenia
		                        			;
		                        		
		                        			Stomach Neoplasms*
		                        			;
		                        		
		                        			Stomatitis
		                        			
		                        		
		                        	
5.The Korean guideline for thyroid cancer screening.
Ka Hee YI ; Soo Young KIM ; Do Hoon KIM ; Sun Wook KIM ; Dong Gyu NA ; You Jin LEE ; Ki Wook CHUNG ; Kui Son CHOI ; Yoon Woo KOH ; Won Bae KIM ; Kee Hyun NAM ; Seung Kuk BAEK ; Jung Hwan BAEK ; Soon Young LEE ; Yuh Seok JUNG ; Jung Jin CHO ; Young Su JU ; Ji Yeon DANG ; Yeol KIM ; Won Chul LEE
Journal of the Korean Medical Association 2015;58(4):302-312
		                        		
		                        			
		                        			Thyroid cancer is the most common malignancy in Korea; in 2012, about 44,000 new cases (19.6% of all malignancies) were registered and the estimated age-standardized incidence rate of thyroid cancer was 73.6 per 100,000 (17.3 and 88.6 per 100,000 in men and women, respectively). Despite the steep increase in its incidence, the age-standardized mortality rate of thyroid cancer has remained stable and 10-year relative survival rate is 99.2%. Increased detection using high-resolution ultrasonography may have contributed to the increased incidence of thyroid cancer if not all. However, the effectiveness of thyroid cancer screening using ultrasonography has not been fully evaluated as to whether screening and early diagnosis could decrease the morbidity or mortality of thyroid cancer. A multidisciplinary expert committee for developing a guideline for thyroid cancer screening was organized and established a recommendation for thyroid cancer screening using ultrasonography in Korea based on scientific evidence for the first time. In conclusion, the current evidence is insufficient to assess the balance of benefits and harms of the thyroid cancer screening by ultrasonography and the recommendation is that thyroid ultrasonography is not routinely recommended for healthy subjects.
		                        		
		                        		
		                        		
		                        			Early Detection of Cancer
		                        			;
		                        		
		                        			Early Diagnosis
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mass Screening*
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Survival Rate
		                        			;
		                        		
		                        			Thyroid Gland
		                        			;
		                        		
		                        			Thyroid Neoplasms*
		                        			;
		                        		
		                        			Ultrasonography
		                        			
		                        		
		                        	
6.The Korean guideline for colorectal cancer screening.
Dae Kyung SOHN ; Min Ju KIM ; Younhee PARK ; Mina SUH ; Aesun SHIN ; Hee Young LEE ; Jong Pil IM ; Hyoen Min CHO ; Sung Pil HONG ; Baek Hui KIM ; Yongsoo KIM ; Jeong Wook KIM ; Hyun Soo KIM ; Chung Mo NAM ; Dong Il PARK ; Jun Won UM ; Soon Nam OH ; Hwan Sub LIM ; Hee Jin CHANG ; Sang Keun HAHM ; Ji Hye CHUNG ; Soo Young KIM ; Yeol KIM ; Won Chul LEE ; Seung Yong JEONG
Journal of the Korean Medical Association 2015;58(5):420-432
		                        		
		                        			
		                        			Colorectal cancer is the third most common cancer in Korea; it is the second most common cancer in men and the third most common in women. The incidence rate in Korea has continuously increased since 1999 when the National Cancer Registry statistics began. Currently; there are several screening modalities; that have been recommended by expert societies, including fecal occult blood test, colonoscopy, computed tomographic colonography The annual fecal immunochemical test (FIT) has been used in adults aged 50 and older as part of the National Cancer Screening Program in Korea since 2004. Although several study results from regional or national colorectal cancer screening programs in other countries have been reported, the National Cancer Screening Program in Korea has not yet been evaluated with evidence-based methods. Herein report the consensus statements on the National Screening Guideline for colorectal cancer developed by a multi-society expert committee in Korea, as follows: 1) We recommend annual or biennial FIT for screening for colorectal cancer in asymptomatic adults, beginning at 45 years of age and continuing until 80 years (recommendation B). 2) There is no evidence for the risks or benefits of FIT in adults older than 80 years (recommendation I). 3) Selective use of colonoscopy for colorectal cancer screening is recommended, taking into consideration individual preference and the risk of colorectal cancer (recommendation C). 4) There is no evidence for the risks or benefits of double-contrast barium enema for colorectal cancer screening in asymptomatic adults (recommendation I). 5) There is no evidence for the risks or benefits of computed tomographic colonography for colorectal cancer screening in asymptomatic adults (recommendation I).
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Barium
		                        			;
		                        		
		                        			Colonography, Computed Tomographic
		                        			;
		                        		
		                        			Colonoscopy
		                        			;
		                        		
		                        			Colorectal Neoplasms*
		                        			;
		                        		
		                        			Consensus
		                        			;
		                        		
		                        			Early Detection of Cancer
		                        			;
		                        		
		                        			Enema
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mass Screening*
		                        			;
		                        		
		                        			Occult Blood
		                        			
		                        		
		                        	
7.An adult asymptomatic pulmonary artery sling.
Han Hee CHUNG ; Ju Yeol BAEK ; Won Yik LEE ; Ji Hye JANG ; Min Young JEONG ; Gi Hyeon WOO ; Seong Il PARK ; Il Kyu KIM
Yeungnam University Journal of Medicine 2014;31(2):109-112
		                        		
		                        			
		                        			A pulmonary artery sling is a very rare congenital abnormality in which the left pulmonary artery rises from the posterior surface of the right pulmonary artery and then passes between the trachea and the esophagus, causing tracheal compression. It is associated with tracheo-bronchial abnormalities (50%) and cardiovascular abnormalities (30%). It may produce respiratory symptoms through the airway compression of the abnormal left pulmonary artery and congenital abnormalities associated with it. Because most (90%) pulmonary artery sling patients present symptoms during infancy, their condition is often diagnosed in the first year of life. However, a pulmonary artery sling is occasionally found in adults. It is usually asymptomatic and found incidentally. This is a very rare case of an asymptomatic pulmonary artery sling in an adult. A 38-year-old man presented symptoms of mild exertional dyspnea. His spiral computed tomography showed a pulmonary artery sling. He was discharged without specific treatment because his symptoms improved without specific treatment and might not have been associated with a pulmonary artery sling. We report an adult case of an asymptomatic pulmonary artery sling diagnosed via spiral computed tomography, accompanied by a literature review.
		                        		
		                        		
		                        		
		                        			Adult*
		                        			;
		                        		
		                        			Cardiovascular Abnormalities
		                        			;
		                        		
		                        			Congenital Abnormalities
		                        			;
		                        		
		                        			Dyspnea
		                        			;
		                        		
		                        			Esophagus
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Pulmonary Artery*
		                        			;
		                        		
		                        			Tomography, Spiral Computed
		                        			;
		                        		
		                        			Trachea
		                        			
		                        		
		                        	
8.A Case of Unruptured Aneurysm of the Right Sinus of Valsalva with Right Ventricular Outflow Obstruction.
Eun CHUNG ; Ju Yeol BAEK ; Han Hee CHUNG ; Seong Il PARK ; Ji Hye JANG ; Hyun A YU ; Gi Hyeon WOO ; Ho Joong YOUN
Korean Circulation Journal 2014;44(4):274-277
		                        		
		                        			
		                        			A 66-year-old man presented with exertional dyspnea. He was found to have an unruptured aneurysm of the right sinus of Valsalva causing significant right ventricular outflow obstruction. This aneurysm was diagnosed by transthoracic two-dimensional echocardiography, transthoracic three-dimensional echocardiography, transesophageal echocardiography, contrast echocardiography and 64-slice multidetector cardiac computed tomography. Because unruptured aneurysms of the sinus of Valsalva are rarely symptomatic, they can be difficult to detect. However, the unruptured aneurysm of the right sinus of Valsalva in this case caused significant right ventricular outflow tract obstruction, resulting in exertional dyspnea.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aneurysm*
		                        			;
		                        		
		                        			Dyspnea
		                        			;
		                        		
		                        			Echocardiography
		                        			;
		                        		
		                        			Echocardiography, Three-Dimensional
		                        			;
		                        		
		                        			Echocardiography, Transesophageal
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Sinus of Valsalva*
		                        			;
		                        		
		                        			Ventricular Outflow Obstruction*
		                        			
		                        		
		                        	
9.A Study on Vascular Pain Due to Gemcitabine and According to Clinical Factors.
So Ryoung SEONG ; Namju LEE ; Mi Jin LEE ; Hyun Ah JANG ; Min Ju SONG ; Se Jung PARK ; Jeeyoon KIM ; Baek Yeol RYOO
Asian Oncology Nursing 2013;13(4):210-221
		                        		
		                        			
		                        			PURPOSE: This study was performed to examine vascular pain due to gemcitabine and according to clinical factors. METHODS: The survey was performed with 525 cancer patients visiting chemotherapy infusion room in one general hospital. The data were collected via self-reported questionnaire, researchers observation, and reviewing medical records. Data were analyzed descriptive statistics, t-test, Kruskal-Wallis test, Tukey test using ranks, Jonckheere-Terpstra test, and Spearman correlation analysis were used. RESULTS: The mean scores of the intensity and onset time of vascular pain were 3.06+/-2.16 and 8.13+/-13.13 min, and each other were negative correlaton. Degree of intensity of vascular pain had a significant difference on gender (p=.003), age (p=.004), weight (p=.019), Body mass index (BMI) (p=.005), Body surface area (BSA) (p=.030), infusion time (p<.001), dose (p=.027), dose per minute (p<.001), the number of administered gemcitabine (p=.005), combination chemotherapeutic drug (p=.013) and tumor type (p=.002). Degree of onset time of vascular pain had a significant difference on infusion time (p=.044), combination chemotherapy (p=.001) and injection site (p=.001). CONCLUSION: Patients administrated gemcitabine were experiencing various vascular pain, and vascular pain had a difference on clinical factors. Therefore, oncology nurses should be considered significant clinical factors to implement effective interventions to patients administered gemcitabine.
		                        		
		                        		
		                        		
		                        			Body Mass Index
		                        			;
		                        		
		                        			Body Surface Area
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Drug Therapy, Combination
		                        			;
		                        		
		                        			Hospitals, General
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Surveys and Questionnaires
		                        			
		                        		
		                        	
10.Impact of Several Types of Stresses on Short-term Memory and Apoptosis in the Hippocampus of Rats.
Bo Kyun KIM ; Il Gyu KO ; Sung Eun KIM ; Chang Ju KIM ; Jee Sang YOON ; Hyung Hwan BAIK ; Byung Kwan JIN ; Choong Yeol LEE ; Sang Bin BAEK ; Mal Soon SHIN
International Neurourology Journal 2013;17(3):114-120
		                        		
		                        			
		                        			PURPOSE: Stress has a deteriorating effect on hippocampal function. It also contributes to symptom exacerbation in many disease states, including overactive bladder and interstitial cystitis/bladder pain syndrome. We investigated the effects of various types of stresses (restraint, noise, and cold) on short-term memory and apoptosis in relation with corticotropin-releasing factor (CRF) expression. METHODS: Rats in the restraint stress group were restrained in a transparent Plexiglas cylinder for 60 minutes twice daily. Rats in the noise stress group were exposed to the 120 dB supersonic machine sound for 60 minutes twice daily. Rats in the cold stress group were placed in a cold chamber at 4degrees C for 60 minutes twice daily. Each stress was applied for 10 days. A step-down avoidance test for short-term memory, immunohistochemistry for caspase-3 expression, and western blot analysis for Bax and Bcl-2 expressions were conducted. RESULTS: Latency time was decreased and CRF expression in the hippocampal dentate gyrus and hypothalamic paraventricular nucleus were increased in all of the stress groups. The number of caspase-3-positive cells in the hippocampal dentate gyrus was increased and the expressions of Bax and Bcl2 in the hippocampus were decreased in all of the stress groups. CONCLUSIONS: All of the stress groups experienced short-term memory impairment induced by apoptosis in the hippocampus. The present results suggest the possibility that these stresses affecting the impairment of short-term memory may also induce functional lower urinary tract disorders.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Apoptosis
		                        			;
		                        		
		                        			Blotting, Western
		                        			;
		                        		
		                        			Caspase 3
		                        			;
		                        		
		                        			Cold Temperature
		                        			;
		                        		
		                        			Corticotropin-Releasing Hormone
		                        			;
		                        		
		                        			Dentate Gyrus
		                        			;
		                        		
		                        			Hippocampus
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Memory, Short-Term
		                        			;
		                        		
		                        			Noise
		                        			;
		                        		
		                        			Paraventricular Hypothalamic Nucleus
		                        			;
		                        		
		                        			Polymethyl Methacrylate
		                        			;
		                        		
		                        			Rats
		                        			;
		                        		
		                        			Urinary Bladder, Overactive
		                        			;
		                        		
		                        			Urinary Tract
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail